Shanghai Institute of Acupuncture-Moxibustion and Merdian
Shanghai, Shanghai Municipality, 200030, China
NCT Number: NCT01697761
The purpose of this study is to determine whether acupuncture or moxibustion therapies are effective in the treatment of active Crohn's disease. meanwhile, we are aim to observe the content of Inflammatory factors and Neurotransmitter before and after acupuncture and moxibustion therapy.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Shanghai, Shanghai Municipality, 200030, China
The purpose of this study is to determine whether acupuncture or moxibustion therapies are effective in the treatment of active Crohn's disease. meanwhile, we are aim to observe the content of Inflammatory factors and Neurotransmitter before and after acupuncture and moxibustion therapy.
Through treating active Crohn's disease by acupuncture and moxibustion therapies for 12 weeks, we are aim to observe the efficiency and the probably change of Inflammatory factors and Neurotransmitter of colonic mucosa and we may elucidate the mechanism of the efficiency of acupuncture and moxibustion therapy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
patients receive herbs-partitioned moxibustion for 2 cones and acupuncture for 30 minutes,3 times a week for 12 weeks
Other names: acupuncture and moxibustion group, acupuncture and Herbs-partitioned moxibustion group
patients receive shallow needing and bran-partitioned moxibustion with the stimulation same to the treatment group.
Other names: Sham acupuncture and moxibustion group
Time frame: 2 years
Crohn's Disease Activity Index
Time frame: 2 years
Intestinal mucosa of Th17/Treg,IL-6,IL-17,IL-23,etc
Time frame: 2 years
Intestinal mucosa of 5-HT,DA,SP,VIP and their receptors etc
Time frame: 2 years
Inflammatory Bowel Disease Questionnaire
Shanghai Institute of Acupuncture, Moxibustion and Meridian
Other
Efficacy of Acupuncture and Moxibustion Treatment in Patients With Active Crohn's Disease and Its Regulation Mechanism to the Immune Homeostasis Mediated by Th17/Treg Cells
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01696838
CAM, Crohn Disease
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT07697547
Crohn Disease, Crohn's Disease
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT01155362
Crohn Disease, Crohn's Disease
Los Angeles, California, United States
View Trial DetailsNCT04002180
Crohn Disease, Crohn's Disease
Tokyo, Japan
View Trial Details